DEADLINE(S)SPONSOROPPORTUNITY TITLE/LINKADDITIONAL INFORMATION

December 1, 2020

NEW (10/26/20)

Alzheimer's AssociationRapid Program in Dementia (RAPID) Funding ProgramThe Alzheimer's Association is offering supplemental funding to early career investigators who currently have active Alzheimer's Association research awards to insure progress on projects in spite of COVID-19 challenges. With this funding, principal investigators (PIs) may address 1) gaps in resources incurred because of the pandemic (e.g., replacing supplies or animal models), or 2) gaps in knowledge which would allow PIs to expand their project aims to increase understanding of COVID-19 effects on the most vulnerable populations.

October 31, 2020
(open for abstract submission through this date for AOI #4 opportunities)

February 3, 2023 or until rescinded for AOI #1, AOI #2 and AOI #6)

(NEW 10/26/20)

Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)

Division of Research Innovations and Ventures Easy Broad Agency Announcement (DRIVe)

See DRIVe EZ BAA Special instructions 010 for details for AOI #4 opportunities

See DRIVe EZ BAA Special Instructions 012 for details on AOI #1, AOI #2 and AOI #6

Open Areas of Interest (AOI) related specifically to COVID-19 are: Remote Patient Monitoring/Remote Diagnostic Tools (AOI #4.1.D); Pediatric Diagnostic Tools for Severe COVID-19 Disease and MIS-C (AOI # 4.1.E); and Alternate Routes of Administration for Vaccines (AOI # 4.3). These AOIs are slated to close October 31, 2020.

An update from 10/22/20 indicates the sponsor has added AOIs to the Broad Agency Announcement that can relate to, but are not specific to, COVID-19: AOI #1 - Early Notification to Act, Control and Treat (ENACT); AOI #2 - Infection Severity and Solving Sepsis; and AOI #6 - Beyond the Needle. These AOIs are currently open through February 3, 2023 (the expiration date of the BAA).

Deadlines begin on or after October 30, 2020 and go through March 16, 2021 - depending on the chosen funding mechanism

NEW (10/26/20)

National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) (NOT-TR-21-006)NCATS is especially interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed Phase I clinical trials to address the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes (COVID-19).

Applications accepted on rolling basis; scientific review occurs in June and December

23andMeResearch Innovation Collaborations ProgramAs related to COVID-19, 23andMe will consider studies of outcomes, co-morbidities, health disparities and impacts of policies implemented to address the pandemic. Academic researchers are paired with 23andMe scientists and gain access to de-identified data from the 23andMe Research Cohort.
November 13, 2020American Association of Orthodontists FoundationCOVID-19 Related OutcomesThe sponsor is offering several funding options for investigator-defined studies concerning COVID-19-related outcomes in orthodontics for their 2021 grants program. Funding mechanisms offered are Postdoctoral Fellowships, Research Awards, Center Awards, Faculty Development Fellowships and Biomedical Research Awards.
Continuous submissionArgonne National Laboratory (US Department of Energy)Expedited, Rapid Access Call for COVID-19 Research SupportThe Advanced Photon Source at Argonne is offering remote access to beamlines for macromolecular crystallography and BioSAXS for research efforts related to SARS-CoV-2 or COVID-19.
No deadline indicatedArmy Applications Laboratory (AAL)COVID-19 InnovationsAAL is seeking information on innovative medical equipment, therapeutics, diagnostics and vaccines relative to COVID-19. The first step is to schedule a telephone call with the agency to discuss your innovative idea(s).

March 17, 2021

Basic Behavioral and Social Science Opportunity Network (NIH OPPNET)Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Well-Being, Illness and Recovery (R01)This Notice adds a deadline date and interests specific to COVID-19.
No deadline specifiedBoehringer IngelheimInvestigator-Initiated Studies (IIS): Established ProductsThe sponsor's purpose is to evaluate potential clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects or antithrombotic benefits.
Continuous submissionBrookhaven National Laboratory (US Department of Energy)COVID-19 Research SupportThe Center for Biomolecular Structure is supporting remote macromolecular crystallography experiments at the AMX and FMX beamlines and solution scattering experiments at the LiX beamline for COVID-19 research.
December 18, 2020Centers for Disease Control and Prevention (CDC)Monitoring Cause-specific School Absenteeism for Estimating Community-Wide Influenza and SARS-CoV-2 Transmission (RFA-CK-21-003)CDC intends to support a research project implementing an influenza-like illness-specific student absentee monitoring system in kindergarten through twelfth grade schools and assess its usability for early detection of influenza, SARS-CoV-2 and other respiratory pathogen transmissions in schools and surrounding communities. 
NOTE: INSTITUTIONS ARE LIMITED TO ONE APPLICATION FOR THIS OPPORTUNITY; OUR INTERNAL SELECTION PROCESS RUNS THROUGH THE OFFICE OF THE VICE CHANCELLOR FOR RESEARCH.
Proposals may be submitted any time; note that interested researchers should respond quickly as Cisco withdraws RFPs when they determine they have met the program goal.Cisco Systems, Inc.

Future of Work (RFP-21-02)

(Scroll down to see open Requests for Proposals)

In light of COVID-19 and the new reality of working from home indefinitely that the pandemic has brought us, Cisco Research Center has released this RFP to encourage research aimed at making the remote work environment more ideal.
Applications accepted on rolling basisCOVID-19 Early Treatment Fund (CETF)Grants ProgramAdvocating early, effective treatment for COVID-19 patients designed to prevent hospitalization, CETF is supporting outpatient clinical trials of re-purposed antiviral drugs. 
Continuous submissionDepartment of Energy
(US DOE)
Dear Colleague Letter - Corona Virus Disease 2019 (COVID-19)DOE is encouraging submission of scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.
Continuous submissionDepartment of Energy (DOE)Rapid Access for COVID-19 ResearchDOE is offering remote access to advanced user facilities to support research into the COVID-19 virus and the search for effective diagnostics and therapeutics.
October 31, 2020
(this is final white paper submission deadline; full proposals will be invited by the sponsor)
Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)Broad Agency Announcement (BAA)BARDA has updated this BAA to reflect its current Areas of Interest (AOI), all related to COVID-19: 
AOI 7.7.1 Diagnostic assay for human coronavirus using existing FDA-cleared platforms; 

AOI 7.7.2 Point-of-care diagnostic assay for  detection of SARS-CoV-2 virus; 
AOI 7.7.3 Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection), Including Serology Tests
AOI 7.7.4 Diagnostic Assay for SARS-CoV-2 as part of FDA-cleared panel for influenza and other respiratory viruses using FDA-cleared platforms
AOI 8.3 COVID-19 Vaccine
AOI 9.2 COVID-19 Therapeutics
AOI 17 Advanced Manufacturing Technologies

October 31, 2020
(open for abstract submission through this date)
Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA)

Division of Research Innovations and Ventures Easy Broad Agency Announcement (DRIVe)

See DRIVe EZ BAA Special instructions 010 for details.

 

While originally published with multiple topics, all have been closed and current work is now devoted to COVID-19. Open Areas of Interest (AOI) are: Remote Patient Monitoring/Remote Diagnostic Tools (AOI #4.1.D); Pediatric Diagnostic Tools for Severe COVID-19 Disease and MIS-C (AOI # 4.1.E); and Alternate Routes of Administration for Vaccines (AOI # 4.3). 

Continuous SubmissionDiamond Light SourceRapid Access Call for Proposals: SARS-CoV-2Diamond, the UK's national synchotron, is offering its facilities and fragment screening expertise to researchers world-wide who are working on COVID-19 related projects.

Applications are due October 22, 2020

e-Asia Joint Research Program (e-Asia JRP)Research Cooperation on Countermeasures for COVID-19This organization encourages and supports collaborative research among investigators in the East Asia region, the US and other countries bordering the Pacific. e-Asia JRP is planning to support multilateral scientific projects to help prevent, diagnose and treat COVID-19. The National Institute of Allergy and Infectious Diseases (NIAID) is a member organization; note NIAID will only support medically related projects.
Applications accepted on rolling basisEmergent VenturesFast Grants for COVID-19The sponsor provides funding for researchers at academic institutions who are currently working on scientific or biomedical COVID-19 projects that could help with the pandemic within the next 6 months. Funding decisions are promised within 14 days for this second round of funding. This grant program is administered by the Mercatus Center at George Mason University.
Applications accepted on a rolling basisEuro Bio-ImagingFast Track Access to Biological and Biomedical Imaging Technologies for COVID-19 Research ProjectsScientists worldwide with ongoing COVID-19 research projects in need of imaging resources will want to consider this opportunity. The sponsor is offering to facilitate access to over 40 biological and biomedical imaging technologies, supporting basic research efforts as well as medical applications and diagnostics.
Continuous submissionExtreme Science and Engineering Discovery Environment (XSEDE)
(funded by the National Science Foundation)
COVID-19 HPC Consortium

This Consortium houses some of the most powerful and advanced computers in the world which will be made available to researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections.

Phase I applications are due September 28, 2020; Semi-Finalist Presentations are scheduled for November 6, 2020; Phase II Presentations will be held November 27, 2020 and Finalist Presentations are set for December 7, 2020.FacebookCOVID-19 Symptom Data ChallengeFacebook and partners have collected COVID-19 symptom surveys in the US and globally and to date have over 30 million responses. Survey collection is ongoing with over 1.5 million new respondents per week. The purpose of this Challenge is to engage data scientists and epidemiologists to work with the data and determine "utility and limitations of symptom survey data in supplementing public health outbreak monitoring and response."
No deadlineFacebookCrowdTangle Public Application for AcademicsUsing Facebook's CrowdTangle, designed to enhance abilities to follow, analyze and report on what's happening across social media, this opportunity will allow researchers to gain access to CrowdTangle tools/technical support. Projects should be focused on misinformation, elections, COVID-19, racial justice and/or well-being. Applications are for access to CrowdSource; no funding is associated with this opportunity.
No deadlinesFacebookNew Preventive Health Survey Data Available for ResearchFacebook has partnered with the Massachusetts Institute for Technology (MIT) Initiative on the Digital Economy and Johns Hopkins University Center for Communication Programs to launch a Preventive Health Survey, designed to assess the public's knowledge, attitude and practices about COVID-19 prevention. Researchers are invited to request aggregated, de-identified survey data; access to  microdata may also be requested but requires a signed data use agreement.
None indicatedFacebookSymptom SurveysFacebook is offering access to survey data collected on a national and global level concerning Facebook users and COVID-19 symptoms. The Symptom Survey datasets are managed by Carnegie Mellon University and the University of Maryland. Academic and non-profit researchers may request access to the aggregated survey data. See the website for more details on survey methodology and the process for requesting data access.
Continuous submission until program funds are expended or the COVID-19 pandemic has endedFederal Communications Commission (FCC)COVID-19 Telehealth ProgramAvailable funding of $200 million for this program comes from the recently enacted CARES Act. It's designed to pay eligible health care providers (to include postsecondary educational institutions offering health care instruction, teaching hospitals and medical schools) to provide connected care services for patients by funding telecommunications services, information services and necessary devices. This is not a grant program; instead, after initial approval, provider expenses related to COVID-19 telehealth services for patients will be reimbursed (starting with expenses incurred after March 13, 2020).

October 1, 2020 for required letters of intent

December 15, 2020 for invited full proposals

Federation of State Medical Boards Foundation (FSMB Foundation)COVID-19 State Response GrantsThis program is designed to offer state medical and osteopathic boards and other health care organizations support for the study of state responses to the COVID-19 pandemic.
Continuous application receipt through October 31, 2020Ferring PharmaceuticalsFerring COVID-19 Investigational Grants in Reproductive Medicine and Maternal HealthFerring will fund exploratory, basic and clinical research efforts about the effects of SARS-CoV-2 on reproduction, pregnancy and fetal/neonatal health. 
December 15, 2020Foundation for a Smoke-Free WorldCOVID-19, Smoking and Nicotine Request for Proposals (RFP)The Foundation will support research pertaining to the impacts of tobacco and nicotine products on COVID-19 outcomes; opportunities for intervention to prevent or reduce COVID-19 infection, hospitalization and disease progression; and interventions to promote healthier lifestyles in the wake of the pandemic.
Submissions will be uploaded on the FIND website on a rolling basisFoundation for Innovative New Diagnostics (FIND)Open Call for Data - COVID-19

This Switzerland-based non-profit is asking laboratories around the world with any performance data on commercially available in vitro diagnostic tests that detect nucleic acid, viral antigen or antibodies to contribute to a centralized collection of data as a global public good. The data compilation will be made available on the FIND website to enable fast data sharing throughout the diagnostic community. 

Applications accepted on a continuous basisFoundation for Opioid Response Efforts (FORE)Strengthening Access to Care for Opioid Use Disorder Patients During the COVID-19 National Public Health Emergency: Recovery Support ServicesFORE will fund projects designed to provide evidence-based opioid use disorder recovery support services in the context of social distancing and infection control including promotion of remote, digital and virtual forms of recovery support to reach vulnerable and high-risk populations. Populations of interest include rural communities, urban and minority communities, children and adolescents, pregnant and parenting women, veterans, justice-involved individuals, homeless individuals, the LGBT community, and Native Americans and tribal communities.
September 21, 2020 for abstract applications; December 21, 2020 for invited full applicationsFoundation for Women's CancerDiversity and Inclusion Health Equity Research GrantsThe sponsor will support research to understand and eliminate inequities in gynecologic cancer care and to increase representation of those underrepresented in gynecologic oncology research and practice. Eligible applicants self-identify as a member of an underrepresented group in cancer research or their application addresses access to care, therapeutic trials and survivorship issues in marginalized populations.
October 30, 2020French Embassy in the US and the US Embassy in FranceTransitioning to Virtual ExchangeInstitutions interested in creatively maintaining French-American collaborations through virtual exchange or other types of global learning in their curricula are invited to submit proposals for this competition. Projects must involve at least one US and one French institution of higher education or international education provider. The key is to demonstrate the potential of their idea to boost study abroad after the pandemic.
October 30, 2020Fundacion MAPFREIgnacio H. de Larramendi Research GrantsFunding projects related to health promotion, this year the sponsor is giving special attention to projects concentrating on COVID-19 (e.g., reducing infections, self-care, relationship between previous health status and morbimortality, mental health). Investigators worldwide are invited to compete.
No deadline indicatedGinkgo BioworksAccess to Platform for Partner COVID-19 ProjectsThe sponsor is offering access to its platform for company and academic labs engaged in developing a diagnostic, drug or vaccine to stop COVID-19.
Applications accepted on a rolling basisGoogle, Inc.COVID-19 Research Credits ProgramGoogle is offering support in the form of Google Cloud research credits to be used for computing services (e.g., storage, computation, data analysis) on Google Cloud Platform for COVID-19 research projects. Note the research credits are meant to fully fund the described project, and credit awards last 90 days.
Ongoing review

William T. Grant Foundation

Spencer Foundation

Rapid Response Research GrantsThe Grant Foundation will use the Rapid Response Research Grants mechanism to fund projects designed to combat youth inequality in the US, a main priority of the Foundation, made worse by the COVID-19 Pandemic. They are joined by the Spencer Foundation in this endeavor. These grants will fund collaborations between researchers and policymakers. Researchers on the team synthesize relevant literature within 6-8 weeks from the start of the grant award, and work with their policy partners to ensure the research results in actions benefiting youth.
December 31, 2020IBSA Foundation for Scientific ResearchFellowship ProgramThe Foundation typically funds fellowships in Dermatology, Endocrinology and other fields and then reserves one category - the Special Edition - for a timely topic. This year's Special Edition is dedicated to coronavirus infections. Researchers under 40 years of age from around the world are invited to apply; eligible candidates have terminal degrees in medicine, biology, pharmacy, biotechnology or bioengineering.
Proposals accepted on a rolling basisInnovations for Poverty Action (IPA)Competitive Fund for Peace and Recovery: COVID-19 ResponseIPA is accepting off-cycle proposals for time-sensitive additions to ongoing research projects that study or support the COVID-19 response such as 1) adding a module to a current survey to track COVID-19 exposure/response; 2) adding a treatment arm to support communities' resiliency in response to COVID-19; 3) Preparing already collected data for sharing quickly.
October 31, 2020Institute of Management Accountants (IMA)2020 Special COVID-19 Call for Research ProposalsIn an effort to offset some of the difficulties facing academics in terms of decreased research and travel funding due to the COVID-19 pandemic, IMA issued this call for proposals. Research topics of interest include revenue management, energy-related decisions, impact of distributed workforce on management control systems, small business issues, measuring intangibles, and digital technology solutions.
January 15, 2021

Johnson & Johnson

American Psychiatric Nurses Association

QuickFire Challenge in Mental HealthThe sponsors are offering funding for projects involving nurse-led novel concepts, educational programs, protocols, prevention or treatment approaches, screening tools or consumer product ideas with the power to transform mental health care and well-being for health care professionals or patients the nurses serve during the COVID-19 pandemic and beyond.
Phase 1 Brief Proposals may be submitted anytime; full proposals will be invited by the sponsorRobert Wood Johnson Foundation (RWJF)Pioneering Ideas: Exploring the Future to Build a Culture of HealthRWJF is looking for future-focused projects in four focus areas to benefit their overall Foundation theme - Building a Culture of Health: 1) Future of Evidence, 2) Future of Social Interaction, 3) Future of Food and 4) Future of Work. Emphasis is on health equity. The sponsor notes that while this opportunity is focused on broader trends evolving prior to COVID-19, they are open to projects addressing the pandemic, either directly or indirectly.
This program is currently on pause; if they find a sponsor, they plan to re-open.Mercatus Center (at George Mason University)COVID-19 Response: A Call for IdeasThe sponsor is seeking proposals for policy briefs, working papers and articles addressing the next COVID-19 challenges facing the US and other countries: Reopening and restarting; institutional challenges, health and science policy; economic and regulatory policy; and monetary policy.
Applications accepted on rolling basisMozilla Open Source Support Program (MOSS)COVID-19 Solutions FundMOSS will fund open source technology projects related to COVID-19. Projects should be relatively well along as awardees are expected to use funds within 3 months of receipt.
Applications accepted through March 29, 2021National Aeronautics and Space Administration (NASA)Rapid Response and Novel Research in Earth Science ProposalNASA will provide new or additional support for studies using NASA satellite data to address regional-to-global environmental, economic and/or societal impacts of the COVID-19 pandemic. NASA is encouraging use of artificial intelligence/machine learning techniques.
Continuous submission (contact program officer first)National Cancer Institute (NCI)Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-Supported Projects to be Redirected to COVID-1-Related Research during the CrisisNCI-funded researchers who wish  to be able to contribute their expertise and resources toward a better understanding of the impacts of SARS-CoV-2 infection and COVID-19 disease on cancer patients’ disease progression, response to therapy, care delivery, or survivorship may request variance to use a portion of their NCI project funds to address this crisis.
Applications accepted on a rolling basis from May 15, 2020 through January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and then advance the translation of research findings into diagnostics, therapeutics, and vaccines.
Applications accepted on rolling basis from May 15, 2020 to January 25, 2022National Center for Advancing Translational Sciences (NCATS)Notice of Special Interest regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusNCATS is interested in three specific topics: 1) Incorporation of new and emerging data related to SARS-CoV-2 into ongoing research efforts to develop microphysiological systems/tissue chips models for COVID-19; 2) Use of microphysiological systems/tissue chips or evaluating, repurposing or modification of diagnostic tools to enable rapid detection of COVID-19 infection; and 3) Use of microphysiological systems/tissue chips for the rapid development and assessment of potential therapeutic agents for COVID-19
Applications accepted on rolling basis and will be handled on an expedited review and award basis; RFA expires January 24, 2021National Center for Advancing Translational Sciences (NCATS)Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) (RFA-TR-20-003)NCATS will fund early-stage clinical trials on existing therapeutic agents that are already marketed or tested in humans in another Phase I clinical trial prior to application submission.
Applications are due beginning with the October 5, 2020 deadline; this NOSI will expire July 6, 2024National Heart, Lung and Blood Institute (NHLBI)Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) (NOT-HL-20-814)NHLBI will accept applications for R01 projects designed to gain a better understanding of host resilience as a critical determinant of outcomes in acute respiratory distress syndrome/acute lung injury.
Applications accepted on a rolling basis through July 7, 2021National Institute of Allergy and Infectious Diseases (NIAID)Limited Competition Emergency Awards: Shared Personal Protective Resources for COVID-19 Related Vaccine and Treatment Clinical Trials (S10 Clinical Trial Not Allowed) (PAR-20-256)NIAID will provide Personal Protective Equipment (PPE) to directly support the needs of NIAID-funded treatment clinical trials and clinical studies on COVID-19. Eligibility is limited to recipients supported by NIAID's emergency appropriation as outlined in the announcement.
Applications will be accepted on the 14th of every month, starting with September 14, 2020 and ending with September 14, 2021National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates against SARS-CoV-2 (NOT-AI-20-065)NIAID will fund cooperative agreements to implement high-risk clinical trials to augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2; specifically, the sponsor is interested in efforts to evaluate candidate vaccines, non-vaccine medical prevention and therapeutic approaches related to SARS-CoV-2.
Applications accepted on a rolling basis through July 2, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-AI-20-059)NIAID replaced NOT-AI-20-034, a more open-ended NOSI, with one in which they are specifying limited interest areas as follows: 1) Support to BSL3 facilities actively engaged in the SARS-CoV-2/COVID-19 research response; 2) Creation of critical reagents to support the SARS-CoV-2/COVID-19 research response; 3) Expansion of relevant data systems to expeditiously share SARS-CoV-2/COVID-19 research resources with the broad research community; and 4) Expansion of clinical trial infrastructure, or site preparation, for urgent SARS-CoV-2/COVID-19 clinical trial activities.
Deadlines vary by funding mechanism; this Notice expires September 8, 2021.National Institute of Allergy and Infectious Diseases (NIAID)Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)Research areas are: Studies to understand critical aspects of viral infection, replication, pathogenesis and transmission; Studies on the evolution and emergence of SARS-CoV-2 viruses; Development of diagnostic tests; Development of SARS-CoV-2 therapeutic candidates; Identification and evaluation of the innate, cellular and humoral immune responses to SARS-CoV-2 infection; and Development of SARS-CoV-2 vaccine candidates. NIAID will be using the Small Grant (R03), SBIR and STTR funding mechanisms.
Proposals may be submitted anytime until further notice; proposal review is promised within one weekNational Institute of Biomedical Imaging and Bioengineering (NIBIB)Fast-Track Program for COVID-19 Test Development and Distribution - Rapid Acceleration of Diagnostics (RADx)The goal of this program is to enable rapid production of innovative SARS-CoV-2 diagnostic tests. Both early and advanced stage projects will be supported.
Deadlines depend on funding mechanism; this NOSI expires March 31, 2021National Institute of Biomedical Imaging and Bioengineering (NIBIB)Notice of Special Interest: Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)The sponsor will fund applications to develop life-saving technologies for commercialization within one to two years.
Applications accepted on rolling basis through November 10, 2020National Institute of Biomedical Imaging and Bioengineering (NIBIB)Notice of Special Interest: Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)NIBIB is seeking applications from current grantees to develop life-saving technologies that can be ready for commercialization within one to two years.
Standard NIH deadlines for R01 and R21 grant mechanisms through July 16, 2023National Institute of Child Health and Human Development (NICHD)Notice of Special Interest (NOSI): Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract (NOT-HD-20-021)NICHD is looking for cutting edge research to investigate possible effects of emerging viruses including SARS-CoV-2 on reproductive tissues and cells to better understand potential impacts in fertility that may be sex specific. Investigators may submit for Research Project (R01) or Exploratory/Developmental Research (R21) Grants.
Deadlines begin on February 5, 2021, depending on the chosen grant mechanism; this NOSI expires March 8, 2023.National Institute of Child Health and Human Development (NICHD)Notice of Special Interest: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic (NOT-HD-20-031)NICHD wishes to fund research addressing the rehabilitation needs of COVID-19 survivors; better understand the impact of disruptions to rehabilitation services caused by COVID-19; and understand the social, behavioral, economic and health impacts of the COVID-19 pandemic on people with physical disabilities. Applications do not have to address all three research interests.

November 2, 2020

National Institute of Dental and Craniofacial Research (NIDCR)Notice of Special Interest: Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCRNIDCR will place high priority on topics of immediate and high impact to protect and ensure safety of personnel and patients in dental practices. These topics include prevention of SARS-COV-2 transmission and improvements in the detection and diagnosis of COVID-19; as well as acquisition of a more robust understanding of SARS-CoV-2 pathogenesis. Topics addressing influence and interaction of sex (a biological variable) and gender (a social construct), race and ethnicity, and those addressing questions about risk, prevention, and health outcomes are also of interest.
December 16, 2020National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) (RFA-DK-20-021)NIDDK will support basic and clinical mechanistic research on susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing disease or adverse acute or chronic outcomes in organs, tissues and biological systems of specific interest to NIDDK (to include diabetes and other metabolic diseases, obesity, endocrine, digestive, liver, pancreas, kidney, urological and hematologic tissues and diseases).
Applications for both types are due November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; and May 3, 2021. This NOSI will expire on May 4, 2021.National Institute of Environmental Health Sciences (NIEHS)Notice of Special Interest: NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)NIEHS will support both time-sensitive new projects and emergency competitive revisions from current grantees to study the role of environmental exposures in pathogenicity, transmission, individual susceptability, or prevention and intervention strategies.

December 2, 2020

March 2, 2021

National Institute of Mental Health (NIMH)

Other Participating Institutes and Centers:

National Eye Institute

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute on Drug Abuse

National Institute of Nursing Research

National Institute on Minority Health and Health Disparities

National Center for Complementary and Integrative Health

National Center for Advancing Translational Sciences

Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) (PAR-20-243)NIMH and partner Institutes and Centers will support research to determine the role and impact of digital-health interventions (e.g., mobile health, telemedicine and telehealth, health information technology, wearable devices) to address secondary health effects of the social, behavioral and economic changes following the COVID-19 pandemic, particularly among populations who experience health disparities and vulnerable populations.
Applications will be accepted on a rolling basis through April 15, 2021.

National Institute of Mental Health (NIMH)

 

Other Participating Institutes:

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel CoronavirusNIMH is especially interested in research to (1) provide an evidence base for how a disrupted workforce may respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, (2) learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health and (3) address the intersection of COVID-19, mental health, and HIV treatment and prevention.
Not applicableNational Institute of Mental Health (NIMH)Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency Caused by Coronavirus 2019 (COVID-19) (NOT-MH-20-061)With the overall goal of more effective human subjects data harmonization, NIMH is offering guidance on the use of consensus-derived common data elements (CDEs) pertaining to mental health outcomes including a set of newly available measures regarding experiences during the COVID-19 public health emergency and exposures to the SARS-CoV-2 virus.
Applications accepted on a rolling basis through December 15, 2020

National Institute of Mental Health

Other Participating NIH Components:
National Eye Institute

National Institute on Aging

National Institute on Alcohol Abuse and Alcoholism 

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Drug Abuse

National Institute of Nursing Research

National Center for Complementary and Integrative Health 

National Center for Advancing Translational Sciences

Notice of Special Interest: Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral and Economic Impact of COVID-19 (NOT-MH-20-053)This NOSI is aimed at current NIH awardees and will use either the Administrative Supplements or Urgent Competitive Revisions mechanisms as outlined in the notice.
Applications accepted through April 14, 2021

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous SystemNINDS will support supplements to address the biology, pathophysiology, prevention, diagnosis, sequelae or treatment of the Novel Coronavirus 2019; NIAAA is interested in studies to better understand, prevent and mitigate some of the neurobiological consequences of SARS-CoV-2 and COVID-19 in individuals with Alcohol Use Disorders.
November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021National institute on Aging (NIA)NIA Multi-Site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Adult Populations (R01 Clinical Trial Required) (PAR-20-234)NIA will support investigator-initiated multi-site clinical trials of interventions focused on specific aging-related issues to reduce transmission, risk, morbidity, mortality or complications of COVID-19; see program announcement for specific priorities.
Applications accepted on a rolling basis from April 6, 2020 through May 1, 2021

National Institute on Aging (NIA)

Other Participating Institutes:

National Institute of Mental Health (NIMH)

Notice of Special Interest: NIH Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019

 

FAQ Document

This NOSI is designed to address the urgent public health need to better understand the 2019-nCoV, particularly to improve prevention of disease transmission among older adults and mitigation of disease severity/mortality in older adults with COVID-19.
November 7, 2020National Institute on Alcohol Abuse and Alcoholism (NIAAA)Alcohol-HIV/AIDS Program Projects Co-Morbidities, Coinfections and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional) (RFA-AA-20-009)NIAAA is soliciting applications for human studies that will advance operations or implementation research in the context of alcohol and HIV/AIDS by facilitating development of broader systems approaches and interventions. Patterns of alcohol use among people living with HIV (PLWH) affect transmission of HIV, engagement and retention in care and  susceptibility to coinfections including COVID-19.
Applications accepted on rolling basis through April 15, 2021National Institute on Alcohol Abuse and Alcoholism (NIAAA)Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAANIAAA is requesting applications to assess the impact of alcohol as a biological contributor to COVID-19 outcomes, to assess behavioral, social, and economic consequences of the pandemic and to assess the responses that the pandemic has provoked as they relate to alcohol consumption and related outcomes.
October 5, 2020 through September 8, 2022 (dependent on specific program announcement - R01 or R21)National Institute on Deafness and Other Communication Disorders (NIDCD)Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders (NOT-DC-20-008)NIDCD will support research on COVID-19 in relation to the Institute's scientific programs: hearing, balance, taste, smell, voice, speech and language.
February 8, 2021
June 8, 2021
October 8, 2021
National Institute on Drug Abuse (NIDA)Notice of Clarification to PAR-19-064, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) (NOT-DA-20-062)NIDA has released a Notice of Clarification for this program announcement, adding an additional priority area concerning risks and outcomes associated with substance use and COVID-19 infection in the general population and among underserved populations.
November 27, 2020
March 17, 2021
November 17, 2021
March 17, 2022
November 17, 2022
February 17, 2023

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating NIH Components:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

Health Services Research on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (PAR-20-310)The sponsor is encouraging health services research efforts that will directly contribute to the improvement of minority health and/or the reduction of health disparities. Research interests include COVID-19.

Standard NIH deadlines apply; the first deadline will be October 5, 2020

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute on Drug Abuse (NIDA)

National Cancer Institute (NCI)

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01 - Clinical Trial Optional)Will support investigative and collaborative research focused on understanding the long-term effects of natural and/or human-made disasters (to include COVID-19) on health care systems serving health disparity populations in communities in the U.S., including the U.S. territories. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations.
Applications accepted on a rolling basis through December 15, 2020

National institute on Minority Health and Health Disparities

Other Participating NIH Components:

National Eye Institute

National Institute on Aging

National Institute on Alcoholism and Alcohol Abuse

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Drug Abuse

National Institute of Environmental Health Sciences

National Institute of Mental Health

National Center for Complementary and Integrative Health

National Center for Advancing Translational Sciences

Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations (NOT-MD-20-022)Key questions include: To what extent do existing interventions slow the spread of COVID-19 in specific populations and geographic hotspots? To what extent do policies, guidelines, and other interventions facilitate adherence and mitigate the multifaceted impacts of COVID-19 on health in populations that experience health disparities and vulnerable groups? Can established models of crisis and disaster response and management be applied to address the needs of health disparity and other vulnerable populations?
Applications accepted on rolling basis through May 1, 2021

National Institute on Minority Health and Health Disparities (NIMHD)

Other Participating Institutes:

National Institute on Aging (NIA)

National Institute of Mental Health (NIMH)

Notice of Special Interest: Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesNIMHD is soliciting research in health disparity populations to better understand: 1) how state and local policies and initiatives mitigate/exacerbate disparities in health services use and health outcomes; 2) the role that community-level protective and resilience factors and interventions have in mitigating the effects of the sector disruptions that the COVID-19 outbreak causes; and 3) how behavioral and/or biological mechanisms may contribute to COVID-19 manifestations.

December 1, 2020

National Institutes of Health (NIH)

Participating Institutes:

National Institute on Minority Health and Health Disparities

National Eye Institute

National Institute on Aging

National institute on Alcohol Abuse and Alcoholism

National Institute of Child Health and Human Development

National Institute on Deafness and Other Communication Disorders

National Institute of Dental and Craniofacial Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Drug Abuse

National Institute of Environmental Health Sciences

National Institute of Mental Health

National Institute of Nursing Research

National Center for Complementary and Integrative Health

National Center for Advancing Translational Sciences

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01 - Clinical Trial Optional) (PAR-20-237)Through this program announcement, NIMHD and other NIH institutes and centers will support research with NIH-designated health disparity populations and other vulnerable groups on community interventions to address the adverse psychosocial, behavioral and socioeconomic effects of SARS-CoV-2 and COVID-19; projects should test 1) impacts of mitigation strategies to prevent COVID-19 transmission and 2) already implemented, new or adapted interventions to address adverse consequences of the pandemic on the health of these groups.
N/ANational Institutes of Health (NIH)Guide Notice of Information Highlighting Harmonization and Data Sharing Expectations for Supplement and Revision Projects Addressing Social, Behavioral, Economic and Health Impacts of the COVID-19 Public Health Emergency (NOT-OD-20-118)NIH has issued a reminder relative to a number of COVID-19 Notices of Special Interest that the agency has "resources and guidance that will facilitate data harmonization and the development of robust data sharing plans."

November 12, 2020

March 12, 2021

July 12, 2021

National Institutes of Health (multiple Institutes and Centers)Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down syndrome for the INCLUDE Project (NOT-OD-20-129)The goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population which may be disproportionately affected by, and/or be at elevated risk for, adverse outcomes from contracting the virus. Multiple institutes and centers are participating and each have specified research objectives as listed in the Notice.
Applications will be accepted according to the standard R01 deadline schedule, starting October 5, 2020; this NOSI expires May 8, 2021

National Institutes of Health (NIH)

 

Participating NIH Components:

 

National Institute of Minority Health and Health Disparities

 

National Institute of Mental Health

 

National Institute on Drug Abuse

 

Office of Disease Prevention

 

National Institute on Deafness and Other Communication Disorders

 

National Cancer Institute

 

National Library of Medicine

 

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities (NOT-MD-20-025)The purpose of this NOSI is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities across a range of illnesses and conditions including the novel coronavirus pandemic.

No set deadline for proposals in response to Dear Colleague Letter

November 18, 2020 for Ecology and Evolution of Infectious Diseases Program

National Science Foundation (NSF)Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)

NSF encourages investigators to use the Rapid Response Research (RAPID) funding mechanism to address COVID-19 which allows for quick turnaround time to meet project requirements. The first step is to contact the program officer as RAPID proposals require program officer permission to submit.

NSF is also encouraging investigators to submit to existing funding opportunities such as the Ecology and Evolution of Infectious Diseases program (EEID), jointly funded by NSF, NIH, USDA and others; EEID proposals are due November 18, 2020.

Frontier Proposals are due December 20, 2020

National Science Foundation/National Institutes of Health (and a host of other federal agencies)Cyber-Physical Systems (CPS)Core research areas of this initiative are control, data analytics and machine learning. NIH mentions supporting "development of CPS research and technology to facilitate medical treatment during a national crisis (e.g., SARS-CoV-2)" (see Section II.D.3 of the program solicitation for details).
March 31, 2021National Science Foundation (NSF)Dear Colleague Letter: Future of International Research Collaboration Post COVID-19NSF's Office of International Science and Engineering (OISE) is interested in funding Rapid Response Research (RAPID) and EArly-concept Grants for Exploratory Research (EAGER) proposals addressing lessons learned from the COVID-19 pandemic that will ultimately benefit international collaborative research efforts.
No set deadlineNational Science Foundation (NSF)Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-2019)

NSF is inviting RAPID proposals and supplemental funding requests to existing awards to address COVID-19 challenges through data and/or software infrastructure development activities. Again, program officer permission is required prior to proposal submission.

Proposals accepted anytimeNational Science Foundation (NSF)Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases (Sentinels) (NSF 20-105)Noting that COVID-19 is unlikely to be the last pandemic in our lifetime, NSF is encouraging use of synthetic biology, cellular engineering, biosensing and immunoengineering as well as other approaches at the intersection of biology and engineering to address the threat of emerging infectious diseases.
November 18, 2020

National Science Foundation (NSF)

National Institutes of Health (NIH)

National Institute of Food and Agriculture (NIFA)

(International sponsors represent Israel, the United Kingdom and China)

Ecology and Evolution of Infectious Diseases (EEID) (NSF 20-585)This program supports research on the ecological, evolutionary and social drivers that influence transmission dynamics of infectious diseases. Note that the central theme of any proposed project must be the quantitative or computational understanding of pathogen transmission dynamics. Multidisciplinary teams are highly encouraged.
Applications accepted on a rolling basis through March 31, 2021

Office of Behavioral and Social Sciences Research (OBSSR)

 

Other Participating Institutes:

National Heart, Lung and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute

Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social SciencesOBSSR is encouraging urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts, including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health.

November 25, 2020

November 26, 2021

National Institutes of Health Office of Research on Women's Health (ORWH)Notice of Change: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) (RFA-OD-20-168)ORWH has issued a Notice of Change for their ongoing Request for Applications (RFA) to include the influence of sex- and gender-related risk factors associated with COVID-19 disease prevalence, treatment and prevention. Studies examining health-seeking behaviors, access to health care and health care systems as related to COVID-19 are also within scope.
Proposals considered on a rolling basisPatient-Centered Outcomes Research Institute (PCORI)COVID-19-Related Enhancements to Existing PCORI-Funded Engagement AwardsOnly PCORI-funded project leads with active Engagement Awards are eligible for this competition. Enhancements may include modest additions to existing aims or an adjunct project that has some relationship to the original award.
Proposals considered on a rolling basisPatient-Centered Outcomes Research Institute (PCORI)COVID-19-Related Enhancements to Existing PCORI-Funded Research ProjectsOnly PCORI-funded principal investigators with active research funding contracts are eligible for this competition. Enhancements may include modest additions to existing aims or an adjunct project that has some relationship to the original award.
November 11, 2020 - deadline for required Letters of InquiryRussell Sage FoundationResearch GrantsFor the previous two deadlines, the Sage Foundation was accepting only COVID-19-related letters of inquiry. For this deadline, they have returned to their core programs: Future of Work; Immigration and Immigrant Integration; Race, Ethnicity and Immigration; Social, Political and Economic Inequality. Within these core programs, applicants may address this topic: Research on the COVID-19 pandemic and the resulting recession in the US.

September 18, 2020 for required one-page concept

October 26, 2020 for invited competitive proposals

Mid-November 2020 - invited finalists will pitch their ideas to a panel of judges

Schmidt FuturesFutures Forum on Learning: Tools CompetitionTeachers, researchers, technologists and ed tech leaders are invited to propose a new tool, technology, platform or research project that can accelerate recovery from COVID-19-related learning loss for K-12 students; the project should also advance the field of learning engineering.
Applications accepted on a rolling basis with first review period to begin August 31, 2020Social Science Research Council (SSRC)Just Tech COVID-19 Rapid-Response GrantsSSRC will support innovative research projects across the social sciences and related fields that use remote research methods to detect short- and long-term implications of public health interventions for a range of rights, liberties and public goods. Areas of interest include contact tracing and public health surveillance; voting access/rights; disparities in health data collection and representation; the digital divide; and remote organizing, campaigning and social movements.
October 31, 2020WORK SAFE BC2020 Request for ProposalsThe sponsor wishes to fund research projects to address direct and indirect impacts of COVID-19 which are unique to occupational health and safety, injured or ill worker recovery and safe and sustainable return to work or stay-at-work. Specific topics of interest to WORK SAFE BC are preventing exposure; addressing the needs of vulnerable workers; working from home; medical, rehabilitative and return to work interventions; and post-viral fatigue. Researchers worldwide are invited to apply.
October 26, 2020World Health Organization (WHO)Call for Proposals: The Ethics of Public Health Emergency Preparedness and ResponseResearch proposals may address any significant ethical aspects of public health preparedness and response to COVID-19. Themes of interest include: Vulnerabilities and inequalities; resource allocation; political responsibilities; containment approaches; surveillance and monitoring; engagement and communication; health systems; data and sample sharing; and research prioritization and oversight.
December 11, 2020World Justice ProjectWorld Justice Challenge 2021: Advancing the Rule of Law in a Time of CrisisThis is a global competition to identify, recognize and promote good practices and high-impact projects/policies that protect and advance the rule of law during and beyond the COVID-19 pandemic.